Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial.
Date:
May 3, 2011
Time:
12:00 - 1:00 p.m. Eastern
Location:
1-866-752-7690 ID 1775282 Speaker(s):
Dr. Christopher Sharpe
Objectives:
1. To discuss the role of tranexamic acid in coagulation/fibrinolysis
2. To discuss the role of tranexamic acid in the prevention of bleeding during surgery and other clinical settings
3. To discuss the role of tranexamic acid in the treatment of bleeding trauma patients
References:
1. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion Henry DA, Carless PA, Moxey AJ et al. Cochrane Database Syst Rev 2011 Mar 16;3
2. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double-blind placebo controlled trial Shakur H, Elbourne D, Gulmezoglu M et al. Trials 2010; 11,40
Downloads:
